Results 101 to 110 of about 135,079 (261)

Uppsala Parkering

open access: yes, 2018
Hög trafikbelastning i storstäder är ett ökande problem som resulterar i ineffektiva trafikmönster. Tid spenderad i köer är överflödig tid som direkt minskar trafikanters dagliga effektivitet. Längre tid i trafiken bidrar dessutom till en högre miljöpåverkan.En relativt stor andel av trafik i storstäder är söktrafik: trafik med mål att hitta en ...
Forssell, Melker   +3 more
openaire   +1 more source

π‐Extended Salphen Scaffolds Enable CO2 Electroreduction and Singlet Oxygen Generation

open access: yesChemistry – A European Journal, EarlyView.
New family of π‐extended salen ligands bearing phenylene bridge and tunable phenyl‐based substituents, and their corresponding boron difluoride complexes. Thanks to the extended π‐delocalization over the molecule, the ligands themselves show promising results in electrochemical CO2 reduction to CO, while the complexes act as efficient photosensitizers ...
Vincenzo Langellotti   +10 more
wiley   +1 more source

Model‐Based Analysis with Mechanistic Insights to CAR‐T‐Cell Therapy Kinetics: Case Study with Axicabtagene Ciloleucel and Brexucabtagene Autoleucel

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Model‐informed drug development is increasingly used to support chimeric antigen receptor (CAR)‐T‐cell therapy programs. However, most population pharmacokinetic (PK) CAR‐T‐cell models available in literature are variations of an empirical piecewise‐linear model, which accurately describes the observed data but lacks a mechanistic foundation.
Anna M. Mc Laughlin   +4 more
wiley   +1 more source

Regulatory Research Priorities for AI Use in the Medicine Lifecycle: A European Perspective with Global Relevance

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Regulatory bodies play a central role in providing guidance that enables safe and effective use of artificial intelligence tools in medicine development and evaluation. Regulators can also act as catalysts for regulatory science research. To inform these efforts, a European‐wide survey was conducted to solicit stakeholder perspectives on the priority ...
Luis C. Pinheiro   +9 more
wiley   +1 more source

Maternal and Neonatal Complications Associated with Breast Cancer Systemic Treatments—A VigiBase Disproportionality Analysis Study

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Pregnancy‐associated breast cancer (PrBC) presents therapeutic challenges. Understanding maternal–fetal safety of systemic anticancer therapies is critical. We performed a case/non‐case disproportionality analysis using the WHO global pharmacovigilance database up to January 2024, to evaluate maternal–fetal outcomes associated with breast cancer (BC ...
Rayan Kabirian   +12 more
wiley   +1 more source

Time‐Dependent Bias and Prognostic Confounding in Exposure–Response Analysis of Targeted Therapies: Lessons from Sunitinib in Metastatic Renal Cancer

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Exposure–response (E–R) analyses of sunitinib in metastatic renal cell carcinoma (mRCC) have supported concentration‐guided dose escalation. However, such analyses may be biased when exposure metrics incorporate post‐baseline dose modifications, time‐varying apparent clearance, or baseline factors that influence both pharmacokinetics and clinical ...
Han Liu, Lena E. Friberg
wiley   +1 more source

Gamla Uppsala

open access: yes, 2003
Platsen är en av Nordens märkligaste kulturmiljöer. Här låg svearnas kungasäte och viktigaste kultplats under järnåldern. Här finns ett av våra största gravområden. Och här stod det kristna Sveriges första ärkebiskopskyrka.
openaire   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy